These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25376085)
1. Anti-angiogenic effect of tanshinone IIA involves inhibition of the VEGF/VEGFR2 pathway in vascular endothelial cells. Xing Y; Tu J; Zheng L; Guo L; Xi T Oncol Rep; 2015 Jan; 33(1):163-70. PubMed ID: 25376085 [TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells. Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102 [TBL] [Abstract][Full Text] [Related]
3. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells. Chuang CH; Liu CH; Lu TJ; Hu ML Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407 [TBL] [Abstract][Full Text] [Related]
4. α-Melanocyte-stimulating hormone inhibits angiogenesis through attenuation of VEGF/VEGFR2 signaling pathway. Weng WT; Huang SC; Ma YL; Chan HH; Lin SW; Wu JC; Wu CY; Wen ZH; Wang EM; Wu CL; Tai MH Biochim Biophys Acta; 2014 Jun; 1840(6):1850-60. PubMed ID: 24530634 [TBL] [Abstract][Full Text] [Related]
5. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs. Chuang IC; Yang CM; Song TY; Yang NC; Hu ML Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173 [TBL] [Abstract][Full Text] [Related]
6. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424 [TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437 [TBL] [Abstract][Full Text] [Related]
8. Coral-derived compound WA-25 inhibits angiogenesis by attenuating the VEGF/VEGFR2 signaling pathway. Lin SW; Huang SC; Kuo HM; Chen CH; Ma YL; Chu TH; Bee YS; Wang EM; Wu CY; Sung PJ; Wen ZH; Wu DC; Sheu JH; Tai MH Mar Drugs; 2015 Feb; 13(2):861-78. PubMed ID: 25668036 [TBL] [Abstract][Full Text] [Related]
9. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling. Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654 [TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis. Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688 [TBL] [Abstract][Full Text] [Related]
11. Lycopene inhibits angiogenesis both in vitro and in vivo by inhibiting MMP-2/uPA system through VEGFR2-mediated PI3K-Akt and ERK/p38 signaling pathways. Chen ML; Lin YH; Yang CM; Hu ML Mol Nutr Food Res; 2012 Jun; 56(6):889-99. PubMed ID: 22707264 [TBL] [Abstract][Full Text] [Related]
12. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer. Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978 [TBL] [Abstract][Full Text] [Related]
13. Jiedu Xiaozheng Yin, a Chinese herbal formula, inhibits tumor angiogenesis via downregulation of VEGF-A and VEGFR-2 expression in vivo and in vitro. Cao Z; Lin W; Huang Z; Chen X; Zhao J; Zheng L; Ye H; Liu Z; Liao L; Du J Oncol Rep; 2013 Mar; 29(3):1080-6. PubMed ID: 23254951 [TBL] [Abstract][Full Text] [Related]
14. 12-Deoxyphorbol 13-palmitate inhibit VEGF-induced angiogenesis via suppression of VEGFR-2-signaling pathway. Xu HY; Pan YM; Chen ZW; Lin Y; Wang LH; Chen YH; Jie TT; Lu YY; Liu JC J Ethnopharmacol; 2013 Apr; 146(3):724-33. PubMed ID: 23434607 [TBL] [Abstract][Full Text] [Related]
15. Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways. Kumar A; Sunita P; Jha S; Pattanayak SP Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):939-50. PubMed ID: 27297262 [TBL] [Abstract][Full Text] [Related]
16. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells. Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633 [TBL] [Abstract][Full Text] [Related]
17. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling. Liu Y; He Y; Yang F; Cong X; Wang J; Peng S; Gao D; Wang W; Lan L; Ying X; Liu M; Chen Y; Yi Z Sci China Life Sci; 2017 Feb; 60(2):202-214. PubMed ID: 28194552 [TBL] [Abstract][Full Text] [Related]
18. Water extract of Cinnamomum cassia suppresses angiogenesis through inhibition of VEGF receptor 2 phosphorylation. Kim EC; Kim HJ; Kim TJ Biosci Biotechnol Biochem; 2015; 79(4):617-24. PubMed ID: 25560253 [TBL] [Abstract][Full Text] [Related]
19. The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells. Wang S; Cai R; Ma J; Liu T; Ke X; Lu H; Fu J Phytomedicine; 2015 Oct; 22(11):1017-26. PubMed ID: 26407944 [TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]